CliffBio
biologic

Odactra

House Dust Mites (Dermatophagoides farinae and Dermatophagoides pteronyssinus) Allergen Extract

Loss of exclusivityMarch 2029projected — 12-year biologic exclusivity estimate
CompanyALK - Abello A/S

Drug detail

Brand nameOdactra
Active ingredientHouse Dust Mites (Dermatophagoides farinae and Dermatophagoides pteronyssinus) Allergen Extract
Strength12 SQ-HDM/ML
Dosage formTablet
RouteSublingual
ModalityBiologic
FDA approvalMarch 2017
Marketing statusRx

More from ALK - Abello A/S

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Odactra patent cliff — loss of exclusivity March 2029 | CliffBio